Showing 36,902 results

PrEP policies & guidelines

Gilead, US square off in billion-dollar HIV drug patent trial

Editor's pick
Reuters
2 May 2023
People who inject drugs

Marketing PrEP to People Who Inject Drugs: A Conversation With David Malebranche, M.D., M.P.H.

Editor's pick
TheBodyPro
2 May 2023
Opportunistic infections

Early ART After Cryptococcal Meningitis Does Not Increase Mortality Risk in HIV

Editor's pick
Infectious Disease Advisor
2 May 2023
Health services & systems

What is the Future of HIV Primary Care?

Editor's pick
HIV and ID Observations
2 May 2023
Human rights

Report on Violations of LGBT People's Rights in Kazakhstan in 2022

Editor's pick
ECOM
3 May 2023
HIV & criminal law

Ugandan parliament sends back bill retaining death penalty for having gay sex when HIV positive to President for signing

Editor's pick
HIV Justice Network
3 May 2023
Opportunistic infections

MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed

Editor's pick
MSF
4 May 2023
HIV & criminal law

Singapore: HIV-positive man jailed over false declarations before donating blood

Editor's pick
The Star
4 May 2023
Pharmaceutical industry

Feds Spent Even More on PrEP Combo Than Previously Thought

Editor's pick
MedPage Today
4 May 2023
Global health initiatives

Fully financing the HIV response would grow African economies by billions

Editor's pick
Be In The Know
4 May 2023
Mpox

Five Men Appear to Have Acquired Mpox Twice

Editor's pick
TheBody
4 May 2023
PrEP programmes & uptake

Study Bite: Among Latinx MSM, PrEP Knowledge Doesn't Always Lead to Use

Editor's pick
TheBodyPro
5 May 2023
People with limited treatment options

Study Bite: Switching to B/F/TAF Plus Doravirine in Multidrug-Resistant PLWH

Editor's pick
TheBodyPro
5 May 2023
Mental & emotional health & wellbeing

New research reveals challenges faced by mothers living with HIV in Indonesia

Editor's pick
Medical Xpress
8 May 2023
How HIV works

Viral reservoir increases on long-term ART: new strategies for a cure

Editor's pick
i-Base
8 May 2023
Sexual health

How Stigma Can Cause Hypervigilance and Impact Sex for People Living With HIV

Editor's pick
TheBody
8 May 2023
Human rights

Terror Descends on LGBTQ Ugandans as Harsh New Anti-Gay Bill Is Passed

Editor's pick
TheBody
8 May 2023
Menopause

Study Bite: Women With HIV Lose Weight During Menopause Transition

Editor's pick
TheBodyPro
8 May 2023
Injectable & long-acting HIV treatment

Study of Weekly Oral HIV Treatment Resumes

Editor's pick
POZ
8 May 2023
Mpox

Mpox cases rise 7% in Africa as Europe reports 17 new infections

Editor's pick
CIDRAP
8 May 2023
PrEP programmes & uptake

South Africa: Uptake of PrEP lower than hoped

Editor's pick
South African Broadcasting Corporation
9 May 2023
Task shifting

South African courts to decide whether pharmacists can start HIV medicines without a doctor’s script

Editor's pick
Spotlight
9 May 2023
Injectable & long-acting PrEP

The anti-HIV injection will be made in South Africa. It could cost between R600 and R800 a pop

Editor's pick
Bhekisisa
9 May 2023
Finance & funding

Gilead Wins Key Patent Rights Suit Over PrEP Drugs for Preventing HIV

Editor's pick
The New York Times
10 May 2023